A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy.
‘Gold standard’ evidence
Cannabidiol (CBD) – a non-intoxicating chemical – reduced seizure frequency by 39% in patients with Dravet Syndrome, researchers report.
The study appears in the New England Journal of Medicine.
This is the first randomised, controlled trial to show that CBD can help control seizures in some people with epilepsy, said study author Dr Orrin Devinsky. He is director of the Comprehensive Epilepsy Center at NYU Langone Medical Center in New York City.